Niacin promotes adipogenesis by reducing production of anti-adipogenic PGF2α through suppression of C/EBPβ-activated COX-2 expression

Prostaglandins and Other Lipid Mediators

Volumn 94, Issue 3-4, 2011, Pages 96-103

  Fujimori, Ko ^a   Amano, Fumio ^a  

^a OSAKA MEDICAL COLLEGE   (Japan)

Author keywords

Adipocytes; C EBP ; COX 2; Niacin; PGF2

Indexed keywords

ADIPONECTIN; CCAAT ENHANCER BINDING PROTEIN ALPHA; CCAAT ENHANCER BINDING PROTEIN BETA; CYCLOOXYGENASE 2; LEPTIN; NICOTINIC ACID; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PROSTAGLANDIN F2 ALPHA; TRIACYLGLYCEROL;

ADIPOCYTE; ADIPOGENESIS; ANIMAL CELL; ARTICLE; CELL LEVEL; CELL VIABILITY; CONTROLLED STUDY; DRUG MECHANISM; ENZYME REPRESSION; FATTY ACID SYNTHESIS; LIPID STORAGE; MOUSE; NONHUMAN; PROTEIN EXPRESSION; RECEPTOR DOWN REGULATION;

3T3-L1 CELLS; ADIPOCYTES; ADIPOGENESIS; ANIMALS; CCAAT-ENHANCER-BINDING PROTEINS; CYCLOOXYGENASE 2; DINOPROST; GENE EXPRESSION REGULATION; MICE; NIACIN; TRIGLYCERIDES;

EID: 79954415539     PISSN: 10988823     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.prostaglandins.2011.01.002     Document Type: Article

References (26)

1. Kershaw EE, Flier JS. Adipose tissue as an endocrine organ. J Clin Endocrinol Metab 2004;89(6):2548-56. (Pubitemid 38766330)
2. Spiegelman BM, Flier JS. Obesity and the regulation of energy balance. Cell 2001;104(4):531-43. (Pubitemid 32201948)
3. Matsuzawa Y. The metabolic syndrome and adipocytokines. FEBS Lett 2006;580(12):2917-21. (Pubitemid 43729162)
4. Visscher TL, Seidell JC. The public health impact of obesity. Annu Rev Public Health 2001;22:355-75. (Pubitemid 32452512)
5. Smith WL, DeWitt DL, Garavito RM. Cyclooxygenases: structural, cellular, and molecular biology. Annu Rev Biochem 2000;69:145-82.
6. Smith WL, Song I. The enzymology of prostaglandin endoperoxide H synthases-1 and -2. Prostaglandins Other Lipid Mediat 2002;68-69:115-28. (Pubitemid 35247391)
7. Fujimori K, Ueno T, Nagata N, et al. Suppression of adipocyte differentiation by aldo-keto reductase 1B3 acting as prostaglandin F2alpha synthase. J Biol Chem 2010;285(12):8880-6.
8. Chu X, Nishimura K, Jisaka M, Nagaya T, Shono F, Yokota K. Up-regulation of adipogenesis in adipocytes expressing stably cyclooxygenase-2 in the antisense direction. Prostaglandins Other Lipid Mediators 2010;91(1-2):1-9.
9. Breyer RM, Bagdassarian CK, Myers SA, Breyer MD. Prostanoid receptors: subtypes and signaling. Annu Rev Pharmacol Toxicol 2001;41:661-90. (Pubitemid 32385902)
10. Narumiya S, Sugimoto Y, Ushikubi F. Prostanoid receptors: structures, properties, and functions. Physiol Rev 1999;79(4):1193-226. (Pubitemid 29473315)
11. Liu L, Clipstone NA. Prostaglandin F2alpha inhibits adipocyte differentiation via a G alpha q-calcium-calcineurin-dependent signaling pathway. J Cell Biochem 2007;100(1):161-73. (Pubitemid 44958187)
12. Henderson LM. Niacin. Annu Rev Nutr 1983;3:289-307.
13. Plaisance EP, Lukasova M, Offermanns S, Zhang Y, Cao G, Judd RL. Niacin stimulates adiponectin secretion through the GPR109A receptor. Am J Physiol Endocrinol Metab 2009;296(3):E549-58.
14. Yang J, Zhao SP, Li J, Dong SZ. Effect of niacin on adipocyte leptin in hypercholesterolemic rabbits. Cardiovasc Pathol 2008;17(4):219-25.
15. Li D, Sun WP, Zhou YM, et al. Chronic niacin overload may be involved in the increased prevalence of obesity in US children. World J Gastroenterol 2010;16(19):2378-87.
16. Fujimori K, Aritake K, Urade Y. A novel pathway to enhance adipocyte differentiation of 3T3-L1 cells by up-regulation of lipocalin-type prostaglandin D synthase mediated by liver X receptor-activated sterol regulatory element-binding protein-1c. J Biol Chem 2007;282(25):18458-66. (Pubitemid 47100233)
17. Healy ZR, Zhu F, Stull JD, Konstantopoulos K. Elucidation of the signaling network of COX-2 induction in sheared chondrocytes: COX-2 is induced via a Rac/MEKK1/MKK7/JNK2/c-Jun-C/EBPbeta-dependent pathway. Am J Physiol Cell Physiol 2008;294(5):C1146-57.
18. Ikezoe T, Yang Y, Saitoh T, et al. PC-SPES down-regulates COX-2 via inhibition of NF-kappaB and C/EBPbeta in non-small cell lung cancer cells. Int J Oncol 2006;29(2):453-61.
19. Lee YS, Terzidou V, Lindstrom T, Johnson M, Bennett PR. The role of CCAAT/enhancer-binding protein beta in the transcriptional regulation of COX-2 in human amnion. Mol Hum Reprod 2005;11(12):853-8.
20. Regalo G, Canedo P, Suriano G, et al. C/EBPbeta is over-expressed in gastric carcinogenesis and is associated with COX-2 expression. J Pathol 2006;210(4):398-404. (Pubitemid 44830599)
21. Wu KK, Liou JY, Cieslik K. Transcriptional control of COX-2 via C/EBPbeta. Arterioscler Thromb Vasc Biol 2005;25(4):679-85. (Pubitemid 40463853)
22. Cartharius K, Frech K, Grote K, et al. MatInspector and beyond: promoter analysis based on transcription factor binding sites. Bioinformatics 2005;21(13):2933-42. (Pubitemid 40916416)
23. Farmer SR. Transcriptional control of adipocyte formation. Cell Metab 2006;4(4):263-73. (Pubitemid 44430910)
24. Tontonoz P, Spiegelman BM. Fat and beyond: the diverse biology of PPARgamma. Annu Rev Biochem 2008;77:289-312.
25. Kadowaki T, Yamauchi T. Adiponectin and adiponectin receptors. Endocr Rev 2005;26(3):439-51. (Pubitemid 40686653)
26. Lefterova MI, Lazar MA. New developments in adipogenesis. Trends Endocrinol Metab 2009;20(3):107-14.